通过专为投资者打造的一站式数据看板，全面查看 Celldex Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

2.97B

股息TTM

0.00

市盈率 TTM

-8.86

每股收益TTM

-4.27

营业收入

1.54M

净利润

-157.86M

净资产收益率

-48.94%

总资产收益率

-45.36%

Celldex Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-10.76%-0.94

-45.86%-1.18

-72.36%-1.22

-58.87%-1.01

-57.03%-0.85

-45.42%-0.81

14.69%-0.71

21.52%-0.64

15.89%-0.54

10.38%-0.56

-48.01%-0.83

---0.81

---0.65

---0.62

---0.56

----

营业收入

-96.99%22.00K

-97.84%15.00K

-89.70%121.00K

-100.00%0.00

-70.78%730.00K

345.51%695.00K

-71.56%1.18M

110.35%3.19M

832.09%2.50M

-83.87%156.00K

156.11%4.13M

272.73%1.52M

64.42%268.00K

455.75%967.00K

382.93%1.61M

166.01%407.00K

-95.32%163.00K

-74.60%174.00K

-91.18%334.00K

-77.10%153.00K

净利润

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36.00M

-39.38%-23.05M

8.00%-20.15M

-43.79%-20.45M

利润率

-4209.12%-334104.55%

-6676.97%-524566.67%

-1576.82%-67204.13%

----

-440.37%-7753.42%

63.19%-7740.43%

-282.31%-4007.83%

47.66%-1319.99%

87.39%-1434.83%

-592.65%-21030.77%

36.16%-1048.32%

---2522.08%

---11381.34%

---3036.30%

---1642.10%

----

毛利率

0.00%100.00%

----

0.00%100.00%

--100.00%

----

资产负债率

----

--0.00%

----

--0.00%

----

利润表

营业收入

-96.99%22.00K

-97.84%15.00K

-89.70%121.00K

-100.00%0.00

-70.78%730.00K

345.51%695.00K

-71.56%1.18M

110.35%3.19M

832.09%2.50M

-83.87%156.00K

156.11%4.13M

272.73%1.52M

64.42%268.00K

455.75%967.00K

382.93%1.61M

166.01%407.00K

-95.32%163.00K

-74.60%174.00K

-91.18%334.00K

-77.10%153.00K

营业利润

-26.26%-80.62M

-34.58%-84.44M

-55.56%-87.15M

-41.23%-73.62M

-37.87%-63.86M

-54.50%-62.74M

-59.50%-56.03M

-26.40%-52.13M

-39.49%-46.32M

-25.06%-40.61M

-25.97%-35.13M

-48.90%-41.24M

-19.78%-33.20M

-36.47%-32.47M

-35.46%-27.89M

-44.06%-27.70M

-110.30%-27.72M

-47.27%-23.79M

-100.57%-20.59M

-40.53%-19.23M

净利润

-29.86%-73.50M

-46.27%-78.69M

-72.68%-81.32M

-59.17%-67.04M

-57.92%-56.60M

-63.97%-53.80M

-8.74%-47.09M

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.50M

-27.38%-29.36M

-31.46%-26.49M

-30.96%-26.78M

-169.23%-36.00M

-39.38%-23.05M

8.00%-20.15M

-43.79%-20.45M

资产负债表

流动资产

11.80%724.93M

-33.81%459.22M

-28.44%534.66M

-22.41%604.34M

-20.14%648.40M

-16.95%693.76M

73.08%747.16M

216.69%778.84M

206.61%811.98M

188.44%835.32M

35.88%431.69M

-26.50%245.93M

-28.03%264.82M

-25.88%289.60M

-22.67%317.69M

-21.56%334.60M

119.55%367.98M

115.26%390.70M

107.66%410.84M

110.20%426.56M

流动负债总额

86.04%61.33M

60.76%51.47M

29.09%50.99M

44.78%46.47M

19.18%32.96M

21.78%32.02M

26.91%39.50M

15.29%32.09M

76.77%27.66M

72.75%26.29M

67.25%31.13M

70.91%27.84M

-47.76%15.65M

4.53%15.22M

12.60%18.61M

14.89%16.29M

106.72%29.95M

-14.24%14.56M

16.35%16.53M

16.20%14.18M

总资产

12.99%782.35M

-30.86%511.25M

-26.42%582.98M

-21.23%648.44M

-18.12%692.41M

-14.89%739.47M

70.17%792.34M

193.72%823.18M

182.51%845.59M

167.73%868.85M

32.00%465.63M

-24.10%280.26M

-25.72%299.31M

-23.47%324.52M

-20.67%352.74M

-19.77%369.23M

97.00%402.96M

93.57%424.04M

88.54%444.65M

79.93%460.20M

总负债

83.20%67.78M

50.80%55.03M

23.12%55.82M

34.35%50.08M

15.89%37.00M

20.69%36.49M

24.36%45.34M

11.14%37.27M

46.63%31.93M

38.82%30.23M

37.41%36.46M

40.86%33.54M

-42.50%21.77M

-16.04%21.78M

5.37%26.53M

1.37%23.81M

70.05%37.87M

4.18%25.94M

-4.92%25.18M

-8.94%23.49M

总权益

9.03%714.56M

-35.10%456.23M

-29.43%527.16M

-23.86%598.36M

-19.45%655.41M

-16.17%702.98M

74.06%747.00M

218.54%785.90M

193.17%813.66M

177.01%838.61M

31.57%429.17M

-28.57%246.72M

-23.98%277.54M

-23.95%302.74M

-22.24%326.20M

-20.91%345.42M

100.29%365.09M

105.03%398.10M

100.36%419.48M

89.90%436.71M

现金流量表

经营净额

-30.46%-57.41M

-20.63%-65.59M

-96.88%-63.94M

12.12%-48.63M

-50.05%-44.01M

-33.80%-54.37M

0.18%-32.48M

-191.35%-55.34M

-7.84%-29.33M

-42.25%-40.64M

-49.49%-32.53M

46.03%-18.99M

-22.26%-27.20M

-16.45%-28.57M

-49.85%-21.76M

-114.95%-35.19M

-86.45%-22.24M

-35.67%-24.53M

-178.70%-14.52M

-38.03%-16.37M

投资净额

-612.58%-255.52M

67.91%72.12M

130.49%55.42M

27.41%60.85M

206.69%49.85M

113.63%42.95M

114.05%24.05M

310.08%47.76M

-4114.00%-46.72M

-699.61%-315.21M

-648.36%-171.16M

-49.51%11.65M

-95.40%1.16M

406.45%52.57M

264.76%31.21M

110.17%23.07M

281.72%25.28M

-76.13%10.38M

-161.40%-18.94M

-433.54%-226.79M

融资净额

515228.57%324.66M

61.88%327.00K

249.48%1.35M

-37.53%774.00K

-98.30%63.00K

-99.95%202.00K

-99.82%386.00K

382.10%1.24M

2690.98%3.71M

62740.35%436.11M

15482.37%217.37M

-88.86%257.00K

87.32%133.00K

128.29%694.00K

227.46%1.40M

-99.15%2.31M

384.00%71.00K

310.81%304.00K

868.18%426.00K

5954.26%271.90M

常见问题

Celldex Therapeutics Inc的总收入是多少？



根据Celldex Therapeutics Inc的FY2025财报，总收入达到了1.54M（同比变化7.02M）。

Celldex Therapeutics Inc的流动资产是多少？



根据Celldex Therapeutics Inc的FY2025财报，流动资产为534.66M（同比变化-28.44）。

Celldex Therapeutics Inc的总资产是多少？



根据Celldex Therapeutics Inc的FY2025财报，Celldex Therapeutics Inc的总资产为582.98M（同比变化-26.42）。

Celldex Therapeutics Inc的总负债是多少？



根据Celldex Therapeutics Inc的FY2025财报，Celldex Therapeutics Inc的总负债为55.82M（同比变化23.12）。

Celldex Therapeutics Inc的总权益是多少？



根据Celldex Therapeutics Inc的FY2025财报，Celldex Therapeutics Inc的总权益为527.16M（同比变化-29.43）。

Celldex Therapeutics Inc的净营业收入是多少？



根据Celldex Therapeutics Inc的FY2025财报，Celldex Therapeutics Inc的净营业收入为-287.37M（同比变化-47.31）。

Celldex Therapeutics Inc的净投资是多少？



根据Celldex Therapeutics Inc的FY2025财报，Celldex Therapeutics Inc的净投资为209.07M（同比变化172.06）。

Celldex Therapeutics Inc的净融资是多少？



根据Celldex Therapeutics Inc的FY2025财报，Celldex Therapeutics Inc的净融资为2.39M（同比变化-99.46）。

Celldex Therapeutics Inc的每股收益（EPS）是多少？



根据Celldex Therapeutics Inc的FY2025财报，每股收益（EPS）为-3.90（同比变化-58.91）。

Celldex Therapeutics Inc的净利润是多少？



根据Celldex Therapeutics Inc的FY2025财报，净利润为-258.76M（同比变化-63.91）。

Celldex Therapeutics Inc的净利润率是多少？



根据Celldex Therapeutics Inc的FY2025财报，净利润率为-16748.03（同比变化-644.77）。

Celldex Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Celldex Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-40.62（同比变化-51.31）。

Celldex Therapeutics Inc的资产回报率（ROA）是多少？



根据Celldex Therapeutics Inc的FY2025财报，资产回报率（ROA）为-37.63（同比变化-49.93）。

Celldex Therapeutics Inc的营业利润是多少？



根据Celldex Therapeutics Inc的FY2025财报，营业利润为-287.37M（同比变化-47.31）。